8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Diva/Boo is a negative regulator of cell death in human glioma cells.

      Febs Letters
      Apoptotic Protease-Activating Factor 1, Caspase 3, Caspase 8, Caspase 9, Caspases, metabolism, Cell Death, drug effects, physiology, Central Nervous System Neoplasms, drug therapy, pathology, Coumarins, Culture Media, Serum-Free, pharmacology, Cytochrome c Group, Enzyme Inhibitors, Fas Ligand Protein, Genes, myc, immunology, Glioma, Humans, Membrane Glycoproteins, Nitrosourea Compounds, Oligopeptides, Proteins, Proto-Oncogene Proteins c-bcl-2, genetics, Teniposide, Transfection, Tumor Cells, Cultured

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Diva is a novel proapoptotic member of the Bcl-2 protein family which binds apoptosis activating factor-1 (APAF-1). Diva is identical with Boo which was identified as a novel antiapoptotic Bcl-2 family protein. Here, we report that Diva promotes the cell cycle exit of human glioma cells in response to serum deprivation and inhibits apoptosis of these cells induced by CD95 ligand or chemotherapeutic drugs. In glioma cells, Diva interferes with apoptotic signaling downstream of cytochrome c release, but upstream of caspase activation, consistent with an inhibitory effect on the mitochondrial amplification step involving the apoptosome and APAF-1.

          Related collections

          Author and article information

          Comments

          Comment on this article